ESC 365 - Pulmonary hypertension due to left heart disease: first validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

HFA Premium Access

Pulmonary hypertension due to left heart disease: first validation of the 2022 definitions in a prospective study, the PH-HF multicenter study

Session: Pulmonary circulation

Topic: Pulmonary Hypertension

Speaker: Doctor C. Fauvel (Rouen, FR)

Event: Heart Failure 2023

Congress Presentation

Add to my library

About the speaker

Doctor Charles Fauvel

University Hospital of Rouen, Rouen (France)

2 presentations

0 follower

3 more presentations in this session

Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: a systematic review and meta-analysis

Speaker: Doctor M. Ansari Ramandi (Groningen, NL)

Soluble ST2 is strongly associated with outcomes in pulmonary arterial hypertension

Speaker: Doctor K. Broch (Oslo, NO)

Right ventricular reverse remodeling after pulmonary endarterectomy and balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension

Speaker: Doctor H. Ravnestad (Oslo, NO)

Access the full session

Pulmonary circulation

Speakers: Doctor C. Fauvel, Doctor M. Ansari Ramandi, Doctor K. Broch, Doctor H. Ravnestad

About the event

Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources